Cytokines in pain

Translational Pain Research: From Mouse to Man

Volumn , Issue , 2009, Pages 187-214

  Shubayev, Veronica I ^a   Kato, Kinshi ^b   Myers, Robert R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057667626     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (162)

1. Altar, C. A., and DiStefano, P. S., 1998. Neurotrophin trafficking by anterograde transport. Trends Neurosci 21, 433–437.
2. Ambron, R. T., Dulin, M. F., Zhang, X. P., Schmied, R., and Walters, E. T., 1995. Axoplasm enriched in a protein mobilized by nerve injury induces memory-like alterations in Aplysia neurons. J Neurosci 15, 3440–3446.
3. Beattie, E. C., Stellwagen, D., Morishita, W., Bresnahan, J. C., Ha, B. K., Von Zastrow, M., Beattie, M. S., and Malenka, R. C., 2002. Control of synaptic strength by glial TNFalpha. Science 295, 2282–2285.
4. Beuche, W., and Friede, R. L., 1984. The role of non-resident cells in Wallerian degeneration. J Neurocytol 13, 767–796.
5. Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., et al. 1997. A metalloproteinase disintegrin that releases tumour-necrosis factoralpha from cells. Nature 385, 729–733.
6. Boulay, J. L., O’Shea, J. J., and Paul, W. E., 2003. Molecular phylogeny within type I cytokines and their cognate receptors. Immunity 19, 159–163.
7. Cavalli, V., Kujala, P., Klumperman, J., and Goldstein, L. S., 2005. Sunday Driver links axonal transport to damage signaling. J Cell Biol 168, 775–787.
8. Chattopadhyay, S., Myers, R. R., Janes, J., and Shubayev, V., 2007. Cytokine regulation of MMP-9 in peripheral glia: implications for pathological processes and pain in injured nerve. Brain Behav Immun 21, 561–568.
9. Cheng, X. P., Wang, B. R., Liu, H. L., You, S. W., Huang, W. J., Jiao, X. Y., and Ju, G., 2003. Phosphorylation of extracellular signal-regulated kinases 1/2 is predominantly enhanced in the microglia of the rat spinal cord following dorsal root transection. Neuroscience 119, 701–712.
10. Choi, J. Y., Choi, Y. S., Kim, S. J., Son, E. J., Choi, H. S., and Yoon, J. H., 2007. Interleukin-1 beta suppresses epithelial sodium channel beta-subunit expression and ENaC-dependent fluid absorption in human middle ear epithelial cells. Eur J Pharmacol 567, 19–25.
11. Cohen, S., and Griffith, S., 2006. Efficacy of epidural etanercept in the treatment of radicular low back pain (LBP). Clinical Trials.gov NCT00374572.
12. Coleman, M., 2005. Axon degeneration mechanisms: commonality amid diversity. Nat Rev Neurosci 6, 889–898.
13. Coleman, M. P., Conforti, L., Buckmaster, E. A., Tarlton, A., Ewing, R. M., Brown, M. C., Lyon, M. F., and Perry, V. H., 1998. An 85-kb tandem triplication in the slow Wallerian degeneration (Wlds) mouse. Proc Natl Acad Sci U S A 95, 9985–9990.
14. Conforti, L., Tarlton, A., Mack, T. G., Mi, W., Buckmaster, E. A., Wagner, D., Perry, V. H., and Coleman, M. P., 2000. A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc Natl Acad Sci U S A 97, 11377–11382.
15. Cooper, R. G., and Freemont, A. J., 2004. TNF-alpha blockade for herniated intervertebral disc-induced sciatica: a way forward at last? Rheumatology (Oxford) 43, 119–121.
16. Cosker, K. E., Courchesne, S. L., and Segal, R. A., 2008. Action in the axon: generation and transport of signaling endosomes. Curr Opin Neurobiol 18, 270–275.
17. Covey, W. C., Ignatowski, T. A., Knight, P. R., and Spengler, R. N., 2000. Brain-derived TNFalpha: involvement in neuroplastic changes implicated in the conscious perception of persistent pain. Brain Res 859, 113–122.
18. Cunningham, A. J., Murray, C. A., O’Neill, L. A., Lynch, M. A., and O’Connor, J. J., 1996. Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett 203, 17–20.
19. Curtis, R., Tonra, J. R., Stark, J. L., Adryan, K. M., Park, J. S., Cliffer, K. D., Lindsay, R. M., and DiStefano, P. S., 1998. Neuronal injury increases retrograde axonal transport of the neurotrophins to spinal sensory neurons and motor neurons via multiple receptor mechanisms. Mol Cell Neurosci 12, 105–118.
20. D’Arcangelo, G., Dodt, H. U., and Zieglgansberger, W., 1997. Reduction of excitation by interleukin-1 beta in rat neocortical slices visualized using infrared-darkfield videomicroscopy. Neuroreport 8, 2079–2083.
21. Daulhac, L., Mallet, C., Courteix, C., Etienne, M., Duroux, E., Privat, A. M., Eschalier, A., and Fialip, J., 2006. Diabetes-induced mechanical hyperalgesia involves spinal mitogenactivated protein kinase activation in neurons and microglia via N-methyl-D-aspartatedependent mechanisms. Mol Pharmacol 70, 1246–1254.
22. De Vos, K. J., Grierson, A. J., Ackerley, S., and Miller, C. C., 2008. Role of axonal transport in neurodegenerative diseases. Annu Rev Neurosci 31, 151–173.
23. DeLeo, J. A., and Winkelstein, B. A., 2002. Physiology of chronic spinal pain syndromes: from animal models to biomechanics. Spine 27, 2526–2537.
24. Diem, R., Meyer, R., Weishaupt, J. H., and Bahr, M., 2001. Reduction of potassium currents and phosphatidylinositol 3-kinase-dependent AKT phosphorylation by tumor necrosis factor-(alpha) rescues axotomized retinal ganglion cells from retrograde cell death in vivo. J Neurosci 21, 2058–2066.
25. Fukuoka, H., Kawatani, M., Hisamitsu, T., and Takeshige, C., 1994. Cutaneous hyperalgesia induced by peripheral injection of interleukin-1 beta in the rat. Brain Res 657, 133–140.
26. Gearing, A. J., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., et al. 1994. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370, 555–557.
27. George, A., Buehl, A., and Sommer, C., 2005. Tumor necrosis factor receptor 1 and 2 proteins are differentially regulated during Wallerian degeneration of mouse sciatic nerve. Exp Neurol 192, 163–166.
28. George, E. B., Glass, J. D., and Griffin, J. W., 1995. Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J Neurosci 15, 6445–6452.
29. Gunstream, J. D., Castro, G. A., and Walters, E. T., 1995. Retrograde transport of plasticity signals in Aplysia sensory neurons following axonal injury. J Neurosci 15, 439–448.
30. Han, J., Lee, J. D., Bibbs, L., and Ulevitch, R. J., 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265, 808–811.
31. Hao, S., Mata, M., Glorioso, J. C., and Fink, D. J., 2006. HSV-mediated expression of interleukin- 4 in dorsal root ganglion neurons reduces neuropathic pain. Mol Pain 2, 6.
32. Hao, S., Mata, M., Glorioso, J. C., and Fink, D. J., 2007. Gene transfer to interfere with TNFalpha signaling in neuropathic pain. Gene Ther 14, 1010–1016.
33. Hargreaves, K., Dubner, R., Brown, F., Flores, C., and Joris, J., 1988. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32, 77–88.
34. Haydon, P. G., 2001. GLIA: listening and talking to the synapse. Nat Rev Neurosci 2, 185–193.
35. Houzen, H., Kikuchi, S., Kanno, M., Shinpo, K., and Tashiro, K., 1997. Tumor necrosis factor enhancement of transient outward potassium currents in cultured rat cortical neurons. J Neurosci Res 50, 990–999.
36. Hu, P., and McLachlan, E. M., 2003. Distinct functional types of macrophage in dorsal root ganglia and spinal nerves proximal to sciatic and spinal nerve transections in the rat. Exp Neurol 184, 590–605.
37. Ji, R. R., Gereau, R. W. t., Malcangio, M., and Strichartz, G. R., 2008. MAP kinase and pain. Brain Res Rev.
38. Ji, R. R., Kawasaki, Y., Zhuang, Z. Y., Wen, Y. R., and Decosterd, I., 2006. Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway. Neuron Glia Biol 2, 259–269.
39. Ji, R. R., Samad, T. A., Jin, S. X., Schmoll, R., and Woolf, C. J., 2002. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36, 57–68.
40. Ji, R. R., and Suter, M. R., 2007. p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain 3, 33.
41. Jin, S. X., Zhuang, Z. Y., Woolf, C. J., and Ji, R. R., 2003. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 23, 4017–4022.
42. Jin, X., and Gereau, R. W. t., 2006. Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha. J Neurosci 26, 246–255.
43. Junger, H., and Sorkin, L. S., 2000. Nociceptive and inflammatory effects of subcutaneous TNF-alpha. Pain 85, 145–151.
44. Karppinen, J., Korhonen, T., Malmivaara, A., Paimela, L., Kyllonen, E., Lindgren, K. A., Rantanen, P., et al. 2003. Tumor necrosis factor-alpha monoclonal antibody, infliximab, used to manage severe sciatica. Spine 28, 750–753; discussion 753–754.
45. Katsuki, H., Nakai, S., Hirai, Y., Akaji, K., Kiso, Y., and Satoh, M., 1990. Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur J Pharmacol 181, 323–326.
46. Kawasaki, Y., Xu, Z. Z., Wang, X., Park, J. Y., Zhuang, Z. Y., Tan, P. H., Gao, Y. J., et al. 2008. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med 14, 331–336.
47. Kenney, A. M., and Kocsis, J. D., 1998. Peripheral axotomy induces long-term c-Jun aminoterminal kinase-1 activation and activator protein-1 binding activity by c-Jun and junD in adult rat dorsal root ganglia In vivo. J Neurosci 18, 1318–1328.
48. Kessler, W., Kirchhoff, C., Reeh, P. W., and Handwerker, H. O., 1992. Excitation of cutaneous afferent nerve endings in vitro by a combination of inflammatory mediators and conditioning effect of substance P. Exp Brain Res 91, 467–476.
49. Kieseier, B. C., Hartung, H. P., and Wiendl, H., 2006. Immune circuitry in the peripheral nervous system. Curr Opin Neurol 19, 437–445.
50. Kita, H., and Armstrong, W., 1991. A biotin-containing compound N-(2-aminoethyl)biotinamide for intracellular labeling and neuronal tracing studies: comparison with biocytin. J Neurosci Methods 37, 141–150.
51. Kobayashi, H., Chattopadhyay, S., Kato, K., Dolkas, J., Kikuchi, S., Myers, R. R., and Shubayev, V. I., 2008. MMPs initiate Schwann cell-mediated MBP degradation and mechanical nociception after nerve damage. Mol Cell Neurosci 39, 619–627.
52. Koike, T., Yang, Y., Suzuki, K., and Zheng, X., 2008. Axon & dendrite degeneration: its mechanisms and protective experimental paradigms. Neurochem Int 52, 751–760.
53. Koller, H., Allert, N., Oel, D., Stoll, G., and Siebler, M., 1998. TNF-alpha induces a protein kinase C-dependent reduction in astroglial K+ conductance. Neuroreport 9, 1375–1378.
54. Komori, K., Nonaka, T., Okada, A., Kinoh, H., Hayashita-Kinoh, H., Yoshida, N., Yana, I., and Seiki, M., 2004. Absence of mechanical allodynia and A-beta-fiber sprouting after sciatic nerve injury in mice lacking membrane-type 5 matrix metalloproteinase. FEBS Lett 557, 125–128.
55. Korhonen, T., Karppinen, J., Malmivaara, A., Autio, R., Niinimaki, J., Paimela, L., Kyllonen, E., et al. 2004. Efficacy of infliximab for disc herniation-induced sciatica: one-year follow- up. Spine 29, 2115–2119.
56. Korhonen, T., Karppinen, J., Paimela, L., Malmivaara, A., Lindgren, K. A., Bowman, C., Hammond, A., et al. 2006. The treatment of disc-herniation-induced sciatica with infliximab: one-year follow-up results of FIRST II, a randomized controlled trial. Spine 31, 2759–2766.
57. Korhonen, T., Karppinen, J., Paimela, L., Malmivaara, A., Lindgren, K. A., Jarvinen, S., Niinimaki, J., Veeger, N., Seitsalo, S., and Hurri, H., 2005. The treatment of disc herniation- induced sciatica with infliximab: results of a randomized, controlled, 3-month follow-up study. Spine 30, 2724–2728.
58. Kraus, J., Borner, C., Giannini, E., Hickfang, K., Braun, H., Mayer, P., Hoehe, M. R., Ambrosch, A., Konig, W., and Hollt, V., 2001. Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J Biol Chem 276, 43901–43908.
59. Kristensson, K., 1984. Retrograde signaling after nerve injury. In: Elam, J. S., and Cancalon, P., (Eds.), Axonal Transport in Growth and Regeneration. Plenum, New York, pp. 31–43.
60. Kumar, A., Zanotti, S., Bunnell, G., Habet, K., Anel, R., Neumann, A., Cheang, M., Dinarello, C. A., Cutler, D., and Parrillo, J. E., 2005. Interleukin-10 blunts the human inflammatory response to lipopolysaccharide without affecting the cardiovascular response. Crit Care Med 33, 331–340.
61. Langer, J. A., Cutrone, E. C., and Kotenko, S., 2004. The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions. Cytokine Growth Factor Rev 15, 33–48.
62. Le Buanec, H., Delavallee, L., Bessis, N., Paturance, S., Bizzini, B., Gallo, R., Zagury, D., and Boissier, M. C., 2006. TNF-alpha kinoid vaccination-induced neutralizing antibodies to TNF-alpha protect mice from autologous TNF-alpha-driven chronic and acute inflammation. Proc Natl Acad Sci U S A 103, 19442–19447.
63. Ledeboer, A., Sloane, E. M., Milligan, E. D., Frank, M. G., Mahony, J. H., Maier, S. F., and Watkins, L. R., 2005. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 115, 71–83.
64. Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., et al. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739–746.
65. Leitner, M. L., Molliver, D. C., Osborne, P. A., Vejsada, R., Golden, J. P., Lampe, P. A., Kato, A. C., Milbrandt, J., and Johnson, E. M., Jr., 1999. Analysis of the retrograde transport of glial cell line-derived neurotrophic factor (GDNF), neurturin, and persephin suggests that in vivo signaling for the GDNF family is GFRalpha coreceptor-specific. J Neurosci 19, 9322–9331.
66. Liefner, M., Siebert, H., Sachse, T., Michel, U., Kollias, G., and Bruck, W., 2000. The role of TNF-alpha during Wallerian degeneration. J Neuroimmunol 108, 147–152.
67. Liu, L., Yang, T. M., Liedtke, W., and Simon, S. A., 2006. Chronic IL-1-beta signaling potentiates voltage-dependent sodium currents in trigeminal nociceptive neurons. J Neurophysiol 95, 1478–1490.
68. Loeser, J. D., and Treede, R. D., 2008. The Kyoto protocol of IASP basic pain terminology. Pain 137, 473–477.
69. Lunn, E. R., Perry, V. H., Brown, M. C., Rosen, H., and Gordon, S., 1989. Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur J Neurosci 1, 27–33.
70. Lyon, M. F., Ogunkolade, B. W., Brown, M. C., Atherton, D. J., and Perry, V. H., 1993. A gene affecting Wallerian nerve degeneration maps distally on mouse chromosome 4. Proc Natl Acad Sci U S A 90, 9717–9720.
71. Ma, C., Greenquist, K. W., and Lamotte, R. H., 2006. Inflammatory mediators enhance the excitability of chronically compressed dorsal root ganglion neurons. J Neurophysiol 95, 2098–2107.
72. Ma, W., and Quirion, R., 2002. Partial sciatic nerve ligation induces increase in the phosphorylation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) in astrocytes in the lumbar spinal dorsal horn and the gracile nucleus. Pain 99, 175–184.
73. Michaelis, M., Vogel, C., Blenk, K. H., Arnarson, A., and Janig, W., 1998. Inflammatory mediators sensitize acutely axotomized nerve fibers to mechanical stimulation in the rat. J Neurosci 18, 7581–7587.
74. Milligan, E. D., Sloane, E. M., Langer, S. J., Hughes, T. S., Jekich, B. M., Frank, M. G., Mahoney, J. H., et al. 2006a. Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain 126, 294–308.
75. Milligan, E. D., Soderquist, R. G., Malone, S. M., Mahoney, J. H., Hughes, T. S., Langer, S. J., Sloane, E. M., et al. 2006b. Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain. Neuron Glia Biol 2, 293–308.
76. Milligan, E. D., Twining, C., Chacur, M., Biedenkapp, J., O’Connor, K., Poole, S., Tracey, K., Martin, D., Maier, S. F., and Watkins, L. R., 2003. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci 23, 1026–1040.
77. Milligan, E. D., and Watkins, L. R., 2009. Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 10, 23–36.
78. Moolwaney, A. S., and Igwe, O. J., 2005. Regulation of the cyclooxygenase-2 system by interleukin- 1 beta through mitogen-activated protein kinase signaling pathways: a comparative study of human neuroglioma and neuroblastoma cells. Brain Res Mol Brain Res 137, 202–212.
79. Murray, C. A., McGahon, B., McBennett, S., and Lynch, M. A., 1997. Interleukin-1 beta inhibits glutamate release in hippocampus of young, but not aged, rats. Neurobiol Aging 18, 343–348.
80. Myers, R. R., Campana, W. M., and Shubayev, V. I., 2006. The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discov Today 11, 8–20.
81. Myers, R. R., Heckman, H. M., and Rodriguez, M., 1996. Reduced hyperalgesia in nerveinjured WLD mice: relationship to nerve fiber phagocytosis, axonal degeneration, and regeneration in normal mice. Exp Neurol 141, 94–101.
82. Myers, R. R., Yamamoto, T., Yaksh, T. L., and Powell, H. C., 1993. The role of focal nerve ischemia and Wallerian degeneration in peripheral nerve injury producing hyperesthesia. Anesthesiology 78, 308–316.
83. Nachemson, A., 2004. Epidemiology and the economics of low back pain. In: Herkowitz, H., Nordin, M., Dvorak, J., Bell, G., and Grob, D., (Eds.), The Lumbar Spine. Lippincott Williams & Wilkins.
84. Nagase, H., 1997. Activation mechanisms of matrix metalloproteinases. Biol Chem 378, 151–160.
85. Obata, K., Yamanaka, H., Dai, Y., Mizushima, T., Fukuoka, T., Tokunaga, A., and Noguchi, K., 2004. Activation of extracellular signal-regulated protein kinase in the dorsal root ganglion following inflammation near the nerve cell body. Neuroscience 126, 1011–1021.
86. Obata, K., Yamanaka, H., Dai, Y., Tachibana, T., Fukuoka, T., Tokunaga, A., Yoshikawa, H., and Noguchi, K., 2003. Differential activation of extracellular signal-regulated protein kinase in primary afferent neurons regulates brain-derived neurotrophic factor expression after peripheral inflammation and nerve injury. J Neurosci 23, 4117–4126.
87. Obreja, O., Rathee, P. K., Lips, K. S., Distler, C., and Kress, M., 2002. IL-1 beta potentiates heat-activated currents in rat sensory neurons: involvement of IL-1RI, tyrosine kinase, and protein kinase C. Faseb J 16, 1497–1503.
88. Ogoshi, F., Yin, H. Z., Kuppumbatti, Y., Song, B., Amindari, S., and Weiss, J. H., 2005. Tumor necrosis-factor-alpha (TNF-alpha) induces rapid insertion of Ca2+-permeable alphaamino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA)/kainate (Ca-A/K) channels in a subset of hippocampal pyramidal neurons. Exp Neurol 193, 384–393.
89. Olmarker, K., and Larsson, K., 1998. Tumor necrosis factor alpha and nucleus-pulposusinduced nerve root injury. Spine 23, 2538–2544.
90. Olmarker, K., Myers, R. R., Kikuchi, S., and Rydevik, B., 2004. Pathophysiology of nerve root pain in disc herniation and spinal stenosis. In: Herkowitz, H., Nordin, M., Dvorak, J., Bell, G., and Grob, D., (Eds.), The Lumbar Spine. Lippincott Williams & Wilkins.
91. Olmarker, K., Rydevik, B., Kikuchi, S., and Myers, R. R., 2005. Sciatic and nerve root pain in disc herniation and spinal stenosis. A basic science review and clinical perspective. In: Herkowitz, H., Balderston, R. A., Garfin, S. R., Eismont, F. J., and Bell, G. R., (Eds.), Rothman-Simeone: The Spine. WB Saunders.
92. Onda, A., Hamba, M., Yabuki, S., and Kikuchi, S., 2002. Exogenous tumor necrosis factoralpha induces abnormal discharges in rat dorsal horn neurons. Spine 27, 1618–1624; discussion 1624.
93. Ozaktay, A. C., Cavanaugh, J. M., Asik, I., DeLeo, J. A., and Weinstein, J. N., 2002. Dorsal root sensitivity to interleukin-1 beta, interleukin-6 and tumor necrosis factor in rats. Eur Spine J 11, 467–475.
94. Ozaktay, A. C., Kallakuri, S., Takebayashi, T., Cavanaugh, J. M., Asik, I., DeLeo, J. A., and Weinstein, J. N., 2006. Effects of interleukin-1 beta, interleukin-6, and tumor necrosis factor on sensitivity of dorsal root ganglion and peripheral receptive fields in rats. Eur Spine J 15, 1529–1537.
95. Page-McCaw, A., Ewald, A. J., and Werb, Z., 2007. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8, 221–233.
96. Perry, V. H., Brown, M. C., Lunn, E. R., Tree, P., and Gordon, S., 1990a. Evidence that very slow Wallerian degeneration in c57bl/ola mice is an intrinsic property of the peripheral nerve. Eur J Neurosci 2, 802–808.
97. Perry, V. H., Lunn, E. R., Brown, M. C., Cahusac, S., and Gordon, S., 1990b. Evidence that the rate of Wallerian degeneration is controlled by a single autosomal dominant gene. Eur J Neurosci 2, 408–413.
98. Plata-Salaman, C. R., and Ffrench-Mullen, J. M., 1992. Interleukin-1 beta depresses calcium currents in CA1 hippocampal neurons at pathophysiological concentrations. Brain Res Bull 29, 221–223.
99. Plata-Salaman, C. R., and Ffrench-Mullen, J. M., 1994. Interleukin-1 beta inhibits Ca2+ channel currents in hippocampal neurons through protein kinase C. Eur J Pharmacol 266, 1–10.
100. Porter, J. T., and McCarthy, K. D., 1997. Astrocytic neurotransmitter receptors in situ and in vivo. Prog Neurobiol 51, 439–455.
101. Rada, P., Mark, G. P., Vitek, M. P., Mangano, R. M., Blume, A. J., Beer, B., and Hoebel, B. G., 1991. Interleukin-1 beta decreases acetylcholine measured by microdialysis in the hippocampus of freely moving rats. Brain Res 550, 287–290.
102. Raghavendra, V., Tanga, F., and DeLeo, J. A., 2003. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 306, 624–630.
103. Redshaw, J. D., and Bisby, M. A., 1984. Fast axonal transport in central nervous system and peripheral nervous system axons following axotomy. J Neurobiol 15, 109–117.
104. Redshaw, J. D., and Bisby, M. A., 1987. Proteins of fast axonal transport in regenerating rat sciatic sensory axons: a conditioning lesion does not amplify the characteristic response to axotomy. Exp Neurol 98, 212–221.
105. Reeve, A. J., Patel, S., Fox, A., Walker, K., and Urban, L., 2000. Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur J Pain 4, 247–257.
106. Romero-Sandoval, E. A., Horvath, R. J., and DeLeo, J. A., 2008. Neuroimmune interactions and pain: focus on glial-modulating targets. Curr Opin Investig Drugs 9, 726–734.
107. Rosenberg, G. A., 2002. Matrix metalloproteinases in neuroinflammation. Glia 39, 279–291.
108. Roux, J., Kawakatsu, H., Gartland, B., Pespeni, M., Sheppard, D., Matthay, M. A., Canessa, C. M., and Pittet, J. F., 2005. Interleukin-1-beta decreases expression of the epithelial sodium channel alpha-subunit in alveolar epithelial cells via a p38 MAPK-dependent signaling pathway. J Biol Chem 280, 18579–18589.
109. Saren, P., Welgus, H. G., and Kovanen, P. T., 1996. TNF-alpha and IL-1-beta selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 157, 4159–4165.
110. Sawada, M., Hara, N., and Maeno, T., 1991. Tumor necrosis factor reduces the ACh-induced outward current in identified Aplysia neurons. Neurosci Lett 131, 217–220.
111. Schafers, M., Brinkhoff, J., Neukirchen, S., Marziniak, M., and Sommer, C., 2001. Combined epineurial therapy with neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 receptor has an additive effect in reducing neuropathic pain in mice. Neurosci Lett 310, 113–116.
112. Schafers, M., Geis, C., Brors, D., Yaksh, T. L., and Sommer, C., 2002. Anterograde transport of tumor necrosis factor-alpha in the intact and injured rat sciatic nerve. J Neurosci 22, 536–545.
113. Schafers, M., Lee, D. H., Brors, D., Yaksh, T. L., and Sorkin, L. S., 2003. Increased sensitivity of injured and adjacent uninjured rat primary sensory neurons to exogenous tumor necrosis factor-alpha after spinal nerve ligation. J Neurosci 23, 3028–3038.
114. Schafers, M., and Sommer, C., 2007. Anticytokine therapy in neuropathic pain management. Expert Rev Neurother 7, 1613–1627.
115. Schafers, M., and Sorkin, L., 2008. Effect of cytokines on neuronal excitability. Neurosci Lett 437, 188–193.
116. Schneider, H., Pitossi, F., Balschun, D., Wagner, A., del Rey, A., and Besedovsky, H. O., 1998. A neuromodulatory role of interleukin-1-beta in the hippocampus. Proc Natl Acad Sci U S A 95, 7778–7783.
117. Scholz, J., and Woolf, C. J., 2007. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10, 1361–1368.
118. Shin, K. C., Lee, S., Moon, S., Min, H., Park, Y., Cho, J., and An, H., 2006. A prospective controlled trial of TNF-alpha inhibitor for symptomatic patients with cervical disc herniation. Spine J 5, 45S.
119. Shubayev, V. I., Angert, M., Dolkas, J., Campana, W. M., Palenscar, K., and Myers, R. R., 2006. TNF-alpha-induced MMP-9 promotes macrophage recruitment into injured peripheral nerve. Mol Cell Neurosci 31, 407–415.
120. Shubayev, V. I., Dolkas, J., Angert, M., and Myers, R. R., 2005. TNF-alpha retrograde axonal transport activates ipsilateral and contralateral spinal glia and DRG gene expression after peripheral nerve injury. J Peripher Nerv Syst 10, 86.
121. Shubayev, V. I., and Myers, R. R., 2000. Upregulation and interaction of TNF-alpha and gelatinases A and B in painful peripheral nerve injury. Brain Res 855, 83–89.
122. Shubayev, V. I., and Myers, R. R., 2001. Axonal transport of TNF-alpha in painful neuropathy: distribution of ligand tracer and TNF receptors. J Neuroimmunol 114, 48–56.
123. Shubayev, V. I., and Myers, R. R., 2002a. Anterograde TNF-alpha transport from rat dorsal root ganglion to spinal cord and injured sciatic nerve. Neurosci Lett 320, 99–101.
124. Shubayev, V. I., and Myers, R. R., 2002b. Endoneurial remodeling by TNF-alpha- and TNFalpha- releasing proteases. A spatial and temporal co-localization study in painful neuropathy. J Peripher Nerv Syst 7, 28–36.
125. Sitcheran, R., Gupta, P., Fisher, P. B., and Baldwin, A. S., 2005. Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNF-alpha-controlled repression. Embo J 24, 510–520.
126. Sommer, C., Lalonde, A., Heckman, H. M., Rodriguez, M., and Myers, R. R., 1995. Quantitative neuropathology of a focal nerve injury causing hyperalgesia. J Neuropathol Exp Neurol 54, 635–643.
127. Sommer, C., and Schafers, M., 1998. Painful mononeuropathy in C57BL/Wld mice with delayed Wallerian degeneration: differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity. Brain Res 784, 154–162.
128. Sommer, C., Schafers, M., Marziniak, M., and Toyka, K. V., 2001. Etanercept reduces hyperalgesia in experimental painful neuropathy. J Peripher Nerv Syst 6, 67–72.
129. Sommer, C., Schmidt, C., George, A., and Toyka, K. V., 1997. A metalloprotease-inhibitor reduces pain associated behavior in mice with experimental neuropathy. Neurosci Lett 237, 45–48.
130. Sorkin, L. S., Xiao, W. H., Wagner, R., and Myers, R. R., 1997. Tumour necrosis factoralpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 81, 255–262.
131. Stellwagen, D., Beattie, E. C., Seo, J. Y., and Malenka, R. C., 2005. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 25, 3219–3228.
132. Stellwagen, D., and Malenka, R. C., 2006. Synaptic scaling mediated by glial TNF-alpha. Nature 440, 1054–1059.
133. Stoll, G., Jander, S., and Myers, R. R., 2002. Degeneration and regeneration of the peripheral nervous system: from Augustus Waller’s observations to neuroinflammation. J Peripher Nerv Syst 7, 13–27.
134. Svensson, C. I., Fitzsimmons, B., Azizi, S., Powell, H. C., Hua, X. Y., and Yaksh, T. L., 2005. Spinal p38-beta isoform mediates tissue injury-induced hyperalgesia and spinal sensitization. J Neurochem 92, 1508–1520.
135. Svensson, C. I., Marsala, M., Westerlund, A., Calcutt, N. A., Campana, W. M., Freshwater, J. D., Catalano, R., et al. 2003. Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing. J Neurochem 86, 1534–1544.
136. Talhouk, R. S., Hajjar, L., Abou-Gergi, R., Simaa’n, C. J., Mouneimne, G., Saade, N. E., and Safieh-Garabedian, B., 2000. Functional interplay between gelatinases and hyperalgesia in endotoxin-induced localized inflammatory pain. Pain 84, 397–405.
137. Tandrup, T., Woolf, C. J., and Coggeshall, R. E., 2000. Delayed loss of small dorsal root ganglion cells after transection of the rat sciatic nerve. J Comp Neurol 422, 172–180.
138. Tobinick, E., 2009. Perispinal etanercept for neuroinflammatory disorders. Drug Discov Today 14, 168–177.
139. Tobinick, E., and Davoodifar, S., 2004. Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients. Curr Med Res Opin 20, 1075–1085.
140. Tonra, J. R., Curtis, R., Wong, V., Cliffer, K. D., Park, J. S., Timmes, A., Nguyen, T., Lindsay, R. M., Acheson, A., and DiStefano, P. S., 1998. Axotomy upregulates the anterograde transport and expression of brain-derived neurotrophic factor by sensory neurons. J Neurosci 18, 4374–4383.
141. Tsuda, M., Ueno, H., Kataoka, A., Tozaki-Saitoh, H., and Inoue, K., 2008. Activation of dorsal horn microglia contributes to diabetes-induced tactile allodynia via extracellular signalregulated protein kinase signaling. Glia 56, 378–386.
142. Vale, M. L., Marques, J. B., Moreira, C. A., Rocha, F. A., Ferreira, S. H., Poole, S., Cunha, F. Q., and Ribeiro, R. A., 2003. Antinociceptive effects of interleukin-4, -10, and -13 on the writhing response in mice and zymosan-induced knee joint incapacitation in rats. J Pharmacol Exp Ther 304, 102–108.
143. Viviani, B., Bartesaghi, S., Gardoni, F., Vezzani, A., Behrens, M. M., Bartfai, T., Binaglia, M., et al. 2003. Interleukin-1-beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 23, 8692–8700.
144. Vogel, C., Stallforth, S., and Sommer, C., 2006. Altered pain behavior and regeneration after nerve injury in TNF receptor deficient mice. J Peripher Nerv Syst 11, 294–303.
145. von Bartheld, C. S., 2004. Axonal transport and neuronal transcytosis of trophic factors, tracers, and pathogens. J Neurobiol 58, 295–314.
146. Wagner, R., Janjigian, M., and Myers, R. R., 1998. Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression. Pain 74, 35–42.
147. Wagner, R., and Myers, R. R., 1996. Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. Neuroreport 7, 2897–2901.
148. Wagner, R., and Myers, R. R., 1996. Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience 73, 625–629.
149. Wajant, H., Pfizenmaier, K., and Scheurich, P., 2003. Tumor necrosis factor signaling. Cell Death Differ 10, 45–65.
150. Watkins, L. R., Hutchinson, M. R., Milligan, E. D., and Maier, S. F., 2007. “Listening” and “talking” to neurons: implications of immune activation for pain control and increasing the efficacy of opioids. Brain Res Rev 56, 148–169.
151. Watkins, L. R., and Maier, S. F., 2002. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 82, 981–1011.
152. Weinstein, J. N., Tosteson, T. D., Lurie, J. D., Tosteson, A. N., Hanscom, B., Skinner, J. S., Abdu, W. A., Hilibrand, A. S., Boden, S. D., and Deyo, R. A., 2006. Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research Trial (SPORT): a randomized trial. Jama 296, 2441–2450.
153. Wieseler-Frank, J., Maier, S. F., and Watkins, L. R., 2004. Glial activation and pathological pain. Neurochem Int 45, 389–395.
154. Williams, L. M., Gibbons, D. L., Gearing, A., Maini, R. N., Feldmann, M., and Brennan, F. M., 1996. Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF-alpha processing in RA synovial membrane cell cultures. J Clin Invest 97, 2833–2841.
155. Woolf, C. J., and Salter, M. W., 2000. Neuronal plasticity: increasing the gain in pain. Science 288, 1765–1769.
156. Yang, S., Liu, Z. W., Wen, L., Qiao, H. F., Zhou, W. X., and Zhang, Y. X., 2005. Interleukin-1- beta enhances NMDA receptor-mediated current but inhibits excitatory synaptic transmission. Brain Res 1034, 172–179.
157. Zhang, J. M., Li, H., Liu, B., and Brull, S. J., 2002. Acute topical application of tumor necrosis factor alpha evokes protein kinase A-dependent responses in rat sensory neurons. J Neurophysiol 88, 1387–1392.
158. Zhang, P., Miller, B. S., Rosenzweig, S. A., and Bhat, N. R., 1996. Activation of C-jun N-terminal kinase/stress-activated protein kinase in primary glial cultures. J Neurosci Res 46, 114–121.
159. Zhao, P., Waxman, S. G., and Hains, B. C., 2007. Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury. J Neurosci 27, 2357–2368.
160. Zhou, C., Ye, H. H., Wang, S. Q., and Chai, Z., 2006. Interleukin-1-beta regulation of N-type Ca2+ channels in cortical neurons. Neurosci Lett 403, 181–185.
161. Zhuang, Z. Y., Gerner, P., Woolf, C. J., and Ji, R. R., 2005. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 114, 149–159.
162. Zhuang, Z. Y., Wen, Y. R., Zhang, D. R., Borsello, T., Bonny, C., Strichartz, G. R., Decosterd, I., and Ji, R. R., 2006. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J Neurosci 26, 3551–3560.